Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial

Authors:

Posted in Papers / Editor's Picks|Human Studies|Original Research / April 16-30, 2025

Lancet Neurol. 2025 May;24(5):429-440. doi: 10.1016/S1474-4422(25)00065-1.

PMID: 40252664 | DOI: 10.1016/S1474-4422(25)00065-1

See related comment.

Read the Original Article

Share this article

Sign Up For An MSC Newsletter

Sign up for:

Register to Watch the MSC Emerging Science Contest!

The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.

REGISTER

Discussion

Leave a Comment

You must be logged in to post a comment.

Search

  • Search

  • Content Types

  • Paper Categories

  • Paper Dates

Paper Categories

By Date